These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 11576621)
1. Effect of glucocorticoid excess on the cortisol/cortisone ratio. Dötsch J; Dörr HG; Stalla GK; Sippell WG Steroids; 2001 Nov; 66(11):817-20. PubMed ID: 11576621 [TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Walker BR; Campbell JC; Fraser R; Stewart PM; Edwards CR Clin Endocrinol (Oxf); 1992 Dec; 37(6):483-92. PubMed ID: 1337504 [TBL] [Abstract][Full Text] [Related]
3. Serum cortisol/cortisone ratio after Synacthen stimulation. Vogeser M; Zachoval R; Jacob K Clin Biochem; 2001 Jul; 34(5):421-5. PubMed ID: 11522281 [TBL] [Abstract][Full Text] [Related]
4. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure. Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185 [TBL] [Abstract][Full Text] [Related]
5. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Palermo M; Shackleton CH; Mantero F; Stewart PM Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758 [TBL] [Abstract][Full Text] [Related]
6. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623 [TBL] [Abstract][Full Text] [Related]
7. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Torpy DJ; Mullen N; Ilias I; Nieman LK Ann N Y Acad Sci; 2002 Sep; 970():134-44. PubMed ID: 12381548 [TBL] [Abstract][Full Text] [Related]
8. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Stewart PM Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516 [TBL] [Abstract][Full Text] [Related]
9. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig. Quinkler M; Troeger H; Eigendorff E; Maser-Gluth C; Stiglic A; Oelkers W; Bähr V; Diederich S J Endocrinol; 2003 Feb; 176(2):185-92. PubMed ID: 12553867 [TBL] [Abstract][Full Text] [Related]
10. [Effects of activity of 11β-hydroxysteroid dehydrogenase type 2 on serum potassium levels in Cushing's syndrome patients]. Lian P; Li H; Zhang Y; Ji Z Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(12):929-32. PubMed ID: 26081057 [TBL] [Abstract][Full Text] [Related]
11. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609 [TBL] [Abstract][Full Text] [Related]
12. Effect of hypercortisolism and ACTH on the metabolism of cortisol. Phillipov G Exp Clin Endocrinol Diabetes; 1998; 106(1):57-60. PubMed ID: 9516061 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Stewart PM; Toogood AA; Tomlinson JW Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677 [TBL] [Abstract][Full Text] [Related]